Legal Representation
Attorney
Brian O'Donnell
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 12, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 12, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 12, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 12, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 12, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 12, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 12, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 12, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 12, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 12, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 12, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 12, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Feb 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 20, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 20, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 25, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 25, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 25, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 25, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 5, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 5, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 18, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 18, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 17, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 17, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 17, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 17, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 17, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 17, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 17, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 17, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 10, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 10, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 3, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Nov 3, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, a drug delivery system consisting of compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents
Class 040
pharmaceutical manufacturing to the order and/or specification of others
Class 042
Development of pharmaceutical and nutraceutical preparations for others, namely, pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents; research and development in the pharmaceutical and nutraceutical fields for others, namely, research and development of pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents
Additional Information
Design Mark
The mark consists of the word "ZIPDOSE" inside a rectangular shape with a right angle corner at the top right, a curved corner at the lower right and a scalloped edge on the left side with four parallel rows of circles and oblongs adjacent the scalloped edge of the rectangle.
Design Mark
The mark consists of the word "ZIPDOSE" inside a rectangular shape with a right angle corner at the top right, a curved corner at the lower right and a scalloped edge on the left side with four parallel rows of circles and oblongs adjacent the scalloped edge of the rectangle.
Color Claim
Color is not claimed as a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ZIP DOSE
Pseudo Mark
ZIP DOSE
Classification
International Classes
005
040
042